WNT7B and breast cancer: Recently reported results demonstrated that the WNT7b expression level in BC was significantly higher than that in the benign breast, and Kaplan–Meier survival curves demonstrated that patients with high WNT7b expression had shorter overall survival (OS) and RFS than those with low WNT7b expression.